Opendata, web and dolomites

EyeWideVision SIGNED

An assessment and treatment tool for visual dysfunctions in children

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EyeWideVision" data sheet

The following table provides information about the project.

Coordinator
E-HEALTH TECHNICAL SOLUTIONS SL 

Organization address
address: C/CANONIGO ALMERA, 10 2 2
city: BARCELONA
postcode: 8032
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://wivivision.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    E-HEALTH TECHNICAL SOLUTIONS SL ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

It is estimated that approximately 30-50% of the general population in children (5-15 years old) suffer from some visual functional dysfunctions, and 10% of them have a serious impairment that affects their daily life. Nevertheless, once detected such dysfunctions can be improved in 95-100% of the cases through training or therapy, but only 2% of these patients are being treated. To solve this problem, we have developed WIVI. WIVI is an assessment and treatment tool for visual dysfunctions detection based on immersive 3D techniques, which examines in a multiparametric way the visual system in its full extension, i.e., it provides a complete cognitive, neural and physic phases assessment. WIVI reduces the standard treatment period from 6 months to 2,5 months, and each session duration is reduced by 75%. Price wise, WIVI allows to save between 58% up to 85% of the total cost of current alternatives. Our product has been tested on 15 children between 5 and 17 years old and on 40 adults in the age range 18 to 70, reaching 95% of accuracy in measurements. The global clinical devices for the visual function assessment market is anticipated to grow from an estimated USD 29,171 million in 2014 to USD 42,685 million in 2020 at a CAGR of 6.5% during the forecast period. The overall objective of the WIVI business project is to establish WIVI as a worldwide standard in visual dysfunction assessment and treatment, supporting it in real-time high detection rates, cheaper and faster clinical practices.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EYEWIDEVISION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EYEWIDEVISION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ICU-CARE (2018)

Delivering BEACON Caresystem – a ground-breaking ICT-enabled ICU bed-side assistant providing recommenda-tions for critical mechanical ventilation support for better care and reduced costs.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More